Published ahead of print on November 1, 2007, doi:10.1164/rccm.200703-390OC
Am. J. Respir. Crit. Care Med., Volume 177, Number 4, February 2008, 402-411
A more recent version of this article appeared on February 15, 2008
Submitted on March 9, 2007
Accepted on November 1, 2007
Gene Expression Profiling in Patients with Chronic Obstructive Pulmonary Disease and Lung Cancer
I-Ming Wang1, Sergey Stepaniants1, Yves Boie2, James R Mortimer2, Brian Kennedy2, Mark Elliott3, Shizu Hayashi3, Leanna Loy3, Silvija Coulter1, Sandra Cervino1, Jennifer Harris2, Michele Thornton1, Richard Raubertas4, Chris Roberts1, Jim C Hogg3, Michael Crackower2, Gary O'Neill2, and Peter D Pare3*
1 Rosetta Inpharmatics, Seattle, WA, USA,
2 Merck Frosst Canada, Montreal, Quebec, Canada,
3 UBC James Hogg iCAPTURE Centre, Providence Health Care, Vancouver, British Columbia, Canada,
4 Merck Frosst Rahway, Rahway, NC, USA
* To whom correspondence should be addressed. E-mail: ppare{at}mrl.ubc.ca.
Rationale: Chronic Obstructive Lung Disease (COPD) is a common and disabling lung disease for which there are few therapeutic options. We reasoned that gene expression profiling of COPD lungs could reveal previously unidentified disease pathways.
Methods and Main Results: 48 human lung samples were obtained from tissue resected from 5 non-smokers, 21 GOLD 0, 9 GOLD 1, 10 GOLD 2 and 3 GOLD 3 patients. mRNA from the specimens was profiled using Agilent's Functional ID v2.0 array containing 23,720 sequences. The gene expression pattern was influenced by the percentage of the sample made up of parenchyma. Gene expression was related to Forced Expiratory Flow between 25 and 75% of forced expiratory volume (FEF 25-75% P) revealing a signature gene set of 203 transcripts. Genes involved in extracellular matrix synthesis/degradation and apoptosis were among the up-regulated genes whereas genes which participate in anti-inflammatory responses were down-regulated. Immunohistochemistry confirmed expression of urokinase (PLAU), urokinanse receptor (PLAUR) and thrombospondin (THBS1) by alveolar macrophages and airway epithelial cells. Genes in this pathway have been shown to be involved in the activation of transforming growth factor beta-1 (TGF [beta] 1) and matrix metalloproteinases (MMP) and are subject to inhibition by SERPINE 2. Interestingly, both TGF beta 1 and SERPINE 2 have been identified as candidate genes in COPD genetic linkage and association studies.
Conclusion: The results provide evidence that genes involved in tissue remodeling and repair are differentially regulated in the lungs of obstructed smokers and suggest that they are potential therapeutic targets.
Clinical Trial Registry Information: ID# GSE8500 registered at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=ldolzqeugcwegfs&acc=GSE8500
Key words: Pulmonary emphysema, phenotype, transcriptional analysis, cigarette smoking
This article has been cited by other articles:
|
|
|
|
 
P. J. Barnes
The Cytokine Network in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Cell Mol. Biol.,
December 1, 2009;
41(6):
631 - 638.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. K. Silverman, A. Spira, and P. D. Pare
Genetics and Genomics of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
September 15, 2009;
6(6):
539 - 542.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. G. Tzortzaki and N. M. Siafakas
A hypothesis for the initiation of COPD
Eur. Respir. J.,
August 1, 2009;
34(2):
310 - 315.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Snyder, A. C. Zemke, and B. R. Stripp
Reparative Capacity of Airway Epithelium Impacts Deposition and Remodeling of Extracellular Matrix
Am. J. Respir. Cell Mol. Biol.,
June 1, 2009;
40(6):
633 - 642.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Punturieri, E. Szabo, T. L. Croxton, S. D. Shapiro, and S. M. Dubinett
Lung Cancer and Chronic Obstructive Pulmonary Disease: Needs and Opportunities for Integrated Research
J Natl Cancer Inst,
April 15, 2009;
101(8):
554 - 559.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D Maclay, R. A Rabinovich, and W. MacNee
Update in Chronic Obstructive Pulmonary Disease 2008
Am. J. Respir. Crit. Care Med.,
April 1, 2009;
179(7):
533 - 541.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Churg, S. Zhou, O. Preobrazhenska, H. Tai, R. Wang, and J. L. Wright
Expression of Profibrotic Mediators in Small Airways versus Parenchyma after Cigarette Smoke Exposure
Am. J. Respir. Cell Mol. Biol.,
March 1, 2009;
40(3):
268 - 276.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Walser, X. Cui, J. Yanagawa, J. M. Lee, E. Heinrich, G. Lee, S. Sharma, and S. M. Dubinett
Smoking and Lung Cancer: The Role of Inflammation
Proceedings of the ATS,
December 1, 2008;
5(8):
811 - 815.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Zeskind, M. E. Lenburg, and A. Spira
Translating the COPD Transcriptome: Insights into Pathogenesis and Tools for Clinical Management
Proceedings of the ATS,
December 1, 2008;
5(8):
834 - 841.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. F. Chung and I. M. Adcock
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Eur. Respir. J.,
June 1, 2008;
31(6):
1334 - 1356.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Howrylak and A. M. K. Choi
Gene Expression Profiling in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
February 15, 2008;
177(4):
364 - 365.
[Full Text]
[PDF]
|
|
|
Copyright © 2007 American Thoracic Society
|
|
|
